![Jeff Caravella](data:image/svg+xml,<svg xmlns="http://www.w3.org/2000/svg" width="16" height="16" fill="%231b1b1b" class="bi bi-person-fill" viewBox="0 0 16 16"><path d="M3 14s-1 0-1-1 1-4 6-4 6 3 6 4-1 1-1 1zm5-6a3 3 0 1 0 0-6 3 3 0 0 0 0 6"/></svg>)
Jeff Caravella
Financieel Directeur/CFO bij
ABIOMED, INC.
Profiel
Jeff Caravella is currently Chief Financial Officer at ABIOMED, Inc. since 2025.
Formerly, Mr. Caravella was Chief Financial Officer at BioTheryX, Inc. and Chief Financial Officer at Medicenna Therapeutics Corp.
in 2023.
Education includes undergraduate and MBAistration degrees from Syracuse University.
Actieve functies van Jeff Caravella
| Bedrijven | Functie | Begin |
|---|---|---|
| ABIOMED, INC. | Financieel Directeur/CFO | 01-01-2025 |
Eerdere bekende functies van Jeff Caravella
| Bedrijven | Functie | Einde |
|---|---|---|
| MEDICENNA THERAPEUTICS CORP. | Financieel Directeur/CFO | 26-10-2023 |
BioTheryX, Inc.
 BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Financieel Directeur/CFO | - |
Opleiding van Jeff Caravella
Ervaring
Beklede functies
Actief
Inactief
Beursgenoteerde bedrijven
Bedrijven in privébezit
Connecties
19
Eerstegraads connecties
4
Bedrijven verbonden in de eerste graad
Man
Vrouw
Besturend
Uitvoerend
Verwante bedrijven
| Bedrijven in privébezit | 4 |
|---|---|
ABIOMED, Inc.
 ABIOMED, Inc. Medical SpecialtiesHealth Technology Manufactures cardiac support, recovery and replacement devices | Health Technology |
BioTheryX, Inc.
BioTheryX, Inc. Packaged SoftwareTechnology Services Operates as a biopharmaceutical company that develops protein degradation platform | Technology Services |
Syracuse University
 Syracuse University Other Consumer ServicesConsumer Services Functions as a College/University | Consumer Services |
Medicenna Therapeutics Corp.
 Medicenna Therapeutics Corp. BiotechnologyHealth Technology Develops biopharmaceuticals | Health Technology |
